American Journal of Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 62.6% | 0.502 | Q3 | 61.0% |
| 2024 | 2.5 | Q3 | 49.0% | 0.583 | Q2 | 67.5% |
| 2023 | 2.9 | Q2 | 59.1% | 0.544 | Q2 | 67.7% |
| 2022 | 4.2 | Q2 | 73.5% | 0.537 | Q2 | 68.5% |
| 2021 | 3.1 | Q3 | 51.9% | 0.406 | Q3 | 60.7% |
| 2020 | — | — | 0.349 | Q3 | 55.2% | |
| 2019 | — | — | 0.378 | Q3 | 59.4% | |
| 2018 | — | — | 0.465 | Q2 | 63.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1536-3686
ISSN
1075-2765
country
UScoverage
1960-1961, 1995-2026